Edoxudine

• CAT Number: I001883
• CAS Number: 15176-29-1
• Molecular Formula: C11H16N2O5
• Molecular Weight: 256.25
• Purity: ≥95%
• Target: Bacterial
• Solubility: 10 mM in H2O
• Storage: Store at -20°C
• IUPAC Name: 5-ethyl-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
• InChI: InChI=1S/C11H16N2O5/c1-2-6-4-13(11(17)12-10(6)16)9-3-7(15)8(5-14)18-9/h4,7-9,14-15H,2-3,5H2,1H3,(H,12,16,17)/t7-,8+,9+/m0/s1
• InChIKey: XACKNLSZYYIACO-DJLDLDEBSA-N
• SMILES: CCC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)O

Edoxudine（Cat No.:I001883）is an antiviral drug in the thymidine analog class, primarily used to treat herpes simplex virus (HSV) infections. It inhibits viral DNA synthesis by integrating into the viral DNA chain, thereby blocking replication. Originally developed for topical use in treating herpes keratitis, Edoxudine effectively targets HSV-infected cells with minimal impact on healthy cells. Although less commonly used today due to the availability of newer antivirals, it remains significant in research on antiviral agents, providing insights into nucleoside analog mechanisms and HSV treatment strategies.